Enzo Biochem has a total of 750 patents globally, out of which 388 have been granted. Of these 750 patents, more than 45% patents are active. United States of America is where Enzo Biochem has filed the maximum number of patents, followed by Israel and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Enzo Biochem.
Enzo Biochem was founded in the year 1976. The Company researches, develops and manufactures health care products based on molecular biology and genetic engineering techniques. The Company also provides diagnostic services to the medical community, labeling and detection products for gene sequencing and genetic analysis are sold to the life sciences market throughout the world. As of April 2023, the market cap of Enzo Biochem is $129.62 Million.
Do read about some of the most popular patents of Enzo Biochem which have been covered by us in this article and also you can find Enzo Biochem patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Enzo Biochem patent portfolio.
How many patents does the founder and the CEO of Enzo Biochem have?
The founder Elazar Rabbani has 44 patents and CEO Hamid R. Erfanian has 0 patent.
How many patents does Enzo Biochem have?
Enzo Biochem has a total of 750 patents globally. These patents belong to 133 unique patent families. Out of 750 patents, 340 patents are active.
How Many Patents did Enzo Biochem File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Enzo Biochem Applications Filed | Enzo Biochem Patents Granted |
| 2023 | – | 3 |
| 2022 | 2 | 4 |
| 2021 | 22 | 21 |
| 2020 | 21 | 36 |
| 2019 | 11 | 33 |
| 2018 | 30 | 39 |
| 2017 | 19 | 35 |
| 2016 | 18 | 56 |
| 2015 | 22 | 26 |
| 2014 | 22 | 19 |
| 2013 | 14 | 34 |
| 2012 | 31 | 18 |
| 2011 | 47 | 10 |
How many Enzo Biochem patents are Alive/Dead?
How Many Patents did Enzo Biochem File in Different Countries?
Countries in which Enzo Biochem Filed Patents
| Country | Patents |
| United States Of America | 271 |
| Israel | 92 |
| Europe | 92 |
| Canada | 86 |
| Germany | 55 |
| Japan | 46 |
| Hong Kong (S.A.R.) | 13 |
| China | 12 |
| Australia | 12 |
| India | 9 |
| Austria | 4 |
| Spain | 2 |
| Portugal | 1 |
| Hungary | 1 |
| Denmark | 1 |
| Poland | 1 |
| Italy | 1 |
Where are Research Centres of Enzo Biochem Patents Located?
10 Best Enzo Biochem Patents
US7495088B1 is the most popular patent in the Enzo Biochem portfolio. It has received 354 citations so far from companies like Procell Therapeutics, Alnylam Pharmaceuticals and Ontorii.
Below is the list of 10 most cited patents of Enzo Biochem:
| Publication Number | Citation Count |
| US7495088B1 | 354 |
| US7064197B1 | 274 |
| US20060025337A1 | 123 |
| US7544497B2 | 122 |
| US20040161741A1 | 107 |
| US20060014705A1 | 106 |
| WO2006102070A2 | 74 |
| US20060084135A1 | 60 |
| US7166478B2 | 46 |
| US7514551B2 | 41 |
How many inventions of other companies were rejected due to Enzo Biochem patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Enzo Biochem invention. They couldn’t because Enzo Biochem had protected those before them.
Examiners at the USPTO referred 34 Enzo Biochem patents in 125 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Enzo Biochem patent portfolio are Life Technologies, National Institutes of Health and Plexbio.
List of the Companies whose Patents were rejected citing Enzo Biochem –
| Company | Number of Patent Applications that faced Rejection Citing Enzo Biochem Patents | Number of Rejections (102 & 103) |
| Life Technologies | 4 | 11 |
| National Institutes Of Health | 3 | 7 |
| Plexbio | 2 | 3 |
| Enzo Therapeutics | 2 | 2 |
| Natural Shield | 1 | 2 |
| Inserm | 1 | 2 |
| Banner Research Institute | 1 | 1 |
| Lsi Medience | 1 | 2 |
| Becton Dickinson | 1 | 2 |
| Self-Screen | 1 | 1 |
Count of 102 and 103 Type Rejections based on Enzo Biochem Patents
Top Enzo Biochem Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US9334281B2 | 4 |
| US20060025337A1 | 4 |
| US9133343B2 | 3 |
| US8124334B2 | 3 |
| US9717754B2 | 3 |
| US7544497B2 | 2 |
| US9156986B2 | 2 |
| US9476873B2 | 2 |
| US7220854B1 | 2 |
| US9261460B2 | 2 |
| US7514551B2 | 2 |
| US9777312B2 | 2 |
| US9403882B2 | 1 |
| US20060084135A1 | 1 |
| US8846893B2 | 1 |
What Percentage of Enzo Biochem US Patent Applications were Granted?
Enzo Biochem (Excluding its subsidiaries) has filed 103 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 54 have been granted leading to a grant rate of 62.79%.
Below are the key stats of Enzo Biochem patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Enzo Biochem?
| Law Firm | Total Applications | Success Rate |
| Quarles & Brady | 97 | 65.43% |
| Ronald C Fedus | 2 | 0.00% |
| C O Fish & Neave | 1 | 0.00% |
| James F Haley | 1 | 0.00% |
| Kramer Levin Naftalis & Frankel | 1 | 0% |
| Natalie Bogdanos | 1 | 100.00% |